NAVELBINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Navelbine, and when can generic versions of Navelbine launch?
Navelbine is a drug marketed by Pierre Fabre and is included in one NDA.
The generic ingredient in NAVELBINE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Navelbine
A generic version of NAVELBINE was approved as vinorelbine tartrate by HIKMA on June 10th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NAVELBINE?
- What are the global sales for NAVELBINE?
- What is Average Wholesale Price for NAVELBINE?
Summary for NAVELBINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Clinical Trials: | 136 |
| Patent Applications: | 4,883 |
| Drug Prices: | Drug price information for NAVELBINE |
| What excipients (inactive ingredients) are in NAVELBINE? | NAVELBINE excipients list |
| DailyMed Link: | NAVELBINE at DailyMed |
Recent Clinical Trials for NAVELBINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| St. Jude Children's Research Hospital | Phase 1/Phase 2 |
| Shantou Central Hospital | Phase 2 |
| Guangdong Provincial People's Hospital | Phase 2 |
US Patents and Regulatory Information for NAVELBINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pierre Fabre | NAVELBINE | vinorelbine tartrate | INJECTABLE;INJECTION | 020388-001 | Dec 23, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NAVELBINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pierre Fabre | NAVELBINE | vinorelbine tartrate | INJECTABLE;INJECTION | 020388-001 | Dec 23, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NAVELBINE
See the table below for patents covering NAVELBINE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Hungary | 182988 | PROCESS FOR PREPARING BIS-INDOLE COMPOUNDS | ⤷ Sign Up |
| Japan | S6332795 | ⤷ Sign Up | |
| France | 2448545 | ⤷ Sign Up | |
| Germany | 2966049 | ⤷ Sign Up | |
| Japan | S5531096 | NOVEL COMPOUND BISSINDOLINE DERIVATIVE ACTIVE AS DRUG AND ITS MANUFACTURE | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for NAVELBINE
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0010458 | SPC/GB96/037 | United Kingdom | ⤷ Sign Up | SPC/GB96/037, EXPIRES: 20040410 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
